{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:35:48Z","timestamp":1790516148190,"version":"4.1.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T00:00:00Z","timestamp":1561680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2019.00563","type":"journal-article","created":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T13:27:16Z","timestamp":1561728436000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Evidence for IL-35 Expression in Diffuse Large B-Cell Lymphoma and Impact on the Patient's Prognosis"],"prefix":"10.3389","volume":"9","author":[{"given":"Fr\u00e9d\u00e9rique","family":"Larousserie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diakho","family":"Kebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Audebourg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Tamburini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eet","family":"Terris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Devergne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,6,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"12041","DOI":"10.1073\/pnas.94.22.12041","article-title":"Epstein-barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin","volume":"94","author":"Devergne","year":"1997","journal-title":"Proc Natl Acad Sci USA."},{"key":"B2","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nature06306","article-title":"The inhibitory cytokine IL-35 contributes to regulatory T-cell function","volume":"450","author":"Collison","year":"2007","journal-title":"Nature."},{"key":"B3","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1002\/eji.200737810","article-title":"IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells","volume":"37","author":"Niedbala","year":"2007","journal-title":"Eur J Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/ni.1952","article-title":"IL-35-mediated induction of a potent regulatory T cell population","volume":"11","author":"Collison","year":"2010","journal-title":"Nat Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/nature12979","article-title":"IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases","volume":"507","author":"Shen","year":"2014","journal-title":"Nature."},{"key":"B6","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nm.3554","article-title":"Interleukin-35 induces regulatory B cells that suppress autoimmune disease","volume":"20","author":"Wang","year":"2014","journal-title":"Nat Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.4049\/jimmunol.1202535","article-title":"Tumor-derived IL-35 promotes tumor growth by enhancing myeloid cell accumulation and angiogenesis","volume":"190","author":"Wang","year":"2013","journal-title":"J Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.immuni.2016.01.013","article-title":"Interleukin-35 limits anti-tumor immunity","volume":"44","author":"Turnis","year":"2016","journal-title":"Immunity."},{"key":"B9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1158\/2159-8290.CD-15-0843","article-title":"IL-35-producing B cells promote the development of pancreatic neoplasia","volume":"6","author":"Pylayeva-Gupta","year":"2016","journal-title":"Cancer Discov."},{"key":"B10","doi-asserted-by":"publisher","first-page":"14035","DOI":"10.1038\/ncomms14035","article-title":"Tumour-derived interleukin 35 promotes pancreatic ductal adenocarcinoma cell extravasation and metastasis by inducing ICAM1 expression","volume":"8","author":"Huang","year":"2017","journal-title":"Nat Commun."},{"key":"B11","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3389\/fimmu.2017.00098","article-title":"Interleukin-35-producing CD8\u03b1+ dendritic cells acquire a tolerogenic state and regulate T cell function","volume":"8","author":"Haller","year":"2017","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"33501","DOI":"10.18632\/oncotarget.16819","article-title":"IL-35 induces N2 phenotype of neutrophils to promote tumor growth","volume":"8","author":"Zou","year":"2017","journal-title":"Oncotarget"},{"key":"B13","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1053\/j.gastro.2017.09.039","article-title":"Interleukin 35 expression correlates with microvessel density in pancreatic ductal adenocarcinoma, recruits monocytes, and promotes growth and angiogenesis of xenograft tumors in mice","volume":"154","author":"Huang","year":"2018","journal-title":"Gastroenterology."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3763","DOI":"10.1038\/s41467-018-06268-0","article-title":"Macrophage-secreted interleukin-35 regulates cancer cell plasticity to facilitate metastatic colonization","volume":"9","author":"Lee","year":"2018","journal-title":"Nat Commun"},{"key":"B15","doi-asserted-by":"publisher","first-page":"6898","DOI":"10.4049\/jimmunol.181.10.6898","article-title":"Human CD4+CD25+Foxp3+ regulatory T cells do not constitutively express IL-35","volume":"181","author":"Bardel","year":"2008","journal-title":"J Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/eji.200939527","article-title":"Human rhinoviruses induce IL-35-producing Treg via induction of B7-H1 (CD274) and sialoadhesin (CD169) on DC. Eur J Immunol","volume":"40","author":"Seyerl","year":"2010"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/S0002-9440(10)63023-4","article-title":"Expression of Epstein-Barr virus-induced gene 3, an interleukin-12 p40-related molecule, throughout human pregnancy: involvement of syncytiotrophoblasts and extravillous trophoblasts","volume":"159","author":"Devergne","year":"2001","journal-title":"Am J Pathol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1002\/eji.201445217","article-title":"Human tolerogenic dendritic cells produce IL-35 in the absence of other IL-12 family members","volume":"45","author":"Dixon","year":"2015","journal-title":"Eur J Immunol."},{"key":"B19","first-page":"1806","article-title":"Assessing the role of IL-35 in colorectal cancer progression and prognosis","volume":"6","author":"Zeng","year":"2013","journal-title":"Int J Clin Exp Pathol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/bjc.2016.47","article-title":"Overexpression of interleukin-35 associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection","volume":"114","author":"Fu","year":"2016","journal-title":"Br J Cancer."},{"key":"B21","doi-asserted-by":"publisher","first-page":"45678","DOI":"10.18632\/oncotarget.10141","article-title":"IL-35 expression in hepatocellular carcinoma cells is associated with tumor progression","volume":"7","author":"Long","year":"2016","journal-title":"Oncotarget."},{"key":"B22","doi-asserted-by":"publisher","first-page":"73003","DOI":"10.18632\/oncotarget.12193","article-title":"Elevated level of interleukin-35 in colorectal cancer induces conversion of T cells into iTr35 by activating STAT1\/STAT3","volume":"7","author":"Ma","year":"2016","journal-title":"Oncotarget."},{"key":"B23","doi-asserted-by":"publisher","first-page":"71563","DOI":"10.18632\/oncotarget.17751","article-title":"Interleukin-35 expression is associated with colon cancer progression","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget."},{"key":"B24","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cyto.2016.09.012","article-title":"Increased interleukin-35 expression in tumor-infiltrating lymphocytes correlates with poor prognosis in patients with breast cancer","volume":"89","author":"Zhao","year":"2017","journal-title":"Cytokine"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1111\/cas.13535","article-title":"Overexpression of interleukin-35 in intrahepatic cholangiocarcinoma is a prognostic indicator after curative resection","volume":"109","author":"Zhang","year":"2018","journal-title":"Cancer Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/path.1995","article-title":"Variable expression of Epstein-Barr virus-induced gene 3 during normal B-cell differentiation and among B-cell lymphomas","volume":"209","author":"Larousserie","year":"2006","journal-title":"J Pathol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e24617","DOI":"10.1371\/journal.pone.0024617","article-title":"Epstein-Barr virus-induced gene 3 (EBI3): a novel diagnosis marker in Burkitt lymphoma and diffuse large B-cell lymphoma","volume":"6","author":"Gonin","year":"","journal-title":"PLoS ONE."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1056\/NEJMoa055351","article-title":"A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling","volume":"354","author":"Hummel","year":"2006","journal-title":"N Engl J Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1056\/NEJMoa055759","article-title":"Molecular diagnosis of Burkitt's lymphoma","volume":"354","author":"Dave","year":"2006","journal-title":"N Engl J Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal gene signatures in large-B-cell lymphomas","volume":"359","author":"Lenz","year":"2008","journal-title":"N Engl J Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1182\/blood-2010-05-285320","article-title":"DNA methylation signatures define molecular subtypes of diffuse large B-cell lymphoma","volume":"116","author":"Shaknovich","year":"2010","journal-title":"Blood"},{"key":"B32","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.humimm.2015.09.020","article-title":"Elevated IL-35 in bone marrow of the patients with acute myeloid leukemia","volume":"76","author":"Wang","year":"2015","journal-title":"Hum Pathol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S1074-7613(02)00324-2","article-title":"IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells","volume":"16","author":"Pflanz","year":"2002","journal-title":"Immunity."},{"key":"B34","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/path.1508","article-title":"Expression of IL-27 in human Th1-associated granulomatous diseases","volume":"202","author":"Larousserie","year":"2004","journal-title":"J Pathol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/path.1217","article-title":"Frequent expression of the Epstein-Barr virus (EBV)-induced gene, EBI3, an IL-12 p40-related cytokine, in Hodgkin and Reed-Sternberg cells","volume":"198","author":"Niedobitek","year":"2002","journal-title":"J Pathol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/S0002-9440(10)62340-1","article-title":"Analysis of interleukin-27 (EBI3\/p28) expression in Epstein-Barr virus- and human T-cell leukemia virus type 1-associated lymphomas: heterogeneous expression of EBI3 subunit by tumoral cells","volume":"166","author":"Larousserie","year":"2005","journal-title":"Am J Pathol."},{"key":"B37","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.4049\/jimmunol.156.3.1207","article-title":"Regulation of bioactive IL-12 production in lipo-polysaccharide-stimulated human monocytes is determined by the expression of the p35 subunit","volume":"156","author":"Snijders","year":"1996","journal-title":"J Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e1026530","DOI":"10.1080\/2162402X.2015.1026530","article-title":"Several immune escape patterns in non-Hodgkin's lymphomas","volume":"4","author":"Laurent","year":"2015","journal-title":"Oncoimmunology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3390\/cancers10110415","article-title":"Profiling immune escape in Hodgkin's and diffuse large B-cell lymphomas using the transcriptome and immunostaining","volume":"10","author":"P\u00e9ricart","year":"2018","journal-title":"Cancers."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1038\/leu.2015.57","article-title":"IL10 receptor is a novel therapeutic target in DLBCLs","volume":"29","author":"B\u00e9guelin","year":"2015","journal-title":"Leukemia."},{"key":"B41","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3389\/fonc.2018.00351","article-title":"Cancer immunotherapy in diffuse large B-cell lymphoma","volume":"8","author":"Zhang","year":"2018","journal-title":"Front Oncol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.1182\/blood-2015-12-686550","article-title":"Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas","volume":"127","author":"Georgiou","year":"2016","journal-title":"Blood."},{"key":"B43","doi-asserted-by":"publisher","first-page":"5358272","DOI":"10.1155\/2016\/5358272","article-title":"Posttranslational modifications and the immunogenicity of biotherapeutics","volume":"2016","author":"Jefferis","year":"2016","journal-title":"J Immunol Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1007\/s00253-016-7388-9","article-title":"Advances in recombinant antibody manufacturing","volume":"100","author":"Kunert","year":"2016","journal-title":"Appl Microbiol Biotechnol."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.00563\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T21:08:34Z","timestamp":1694984914000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.00563\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,28]]},"references-count":44,"alternative-id":["10.3389\/fonc.2019.00563"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2019.00563","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,28]]},"article-number":"563"}}